Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
UBS
Merck
Express Scripts
Deloitte

Generated: May 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,085,974

« Back to Dashboard

Summary for Patent: 10,085,974
Title:Dosage and formulation
Abstract: The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide.
Inventor(s): Casado; Rosa Lamarca (Barcelona, ES), Serra; Gonzalo De Miquel (Barcelona, ES)
Assignee: Almirall, S.A. (Barcelona, ES)
Application Number:13/692,032
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 10,085,974
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 10,085,974

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Astrazeneca Pharms TUDORZA PRESSAIR aclidinium bromide POWDER, METERED;INHALATION 202450-001 Jul 23, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) OR CHRONIC BRONCHITIS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 10,085,974

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
08382010Mar 13, 2008

International Family Members for US Patent 10,085,974

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 070835 ➤ Try a Free Trial
Australia 2009224895 ➤ Try a Free Trial
Brazil PI0905775 ➤ Try a Free Trial
Canada 2716724 ➤ Try a Free Trial
China 102083416 ➤ Try a Free Trial
China 104473911 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
Teva
Boehringer Ingelheim
Baxter
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.